🇺🇸 FDA
Company

GT

GT Biopharma

GTBP biotech USA

Quick answer

GT is a biotech company (GTBP) headquartered in SAN FRANCISCO, CA, USA with 8 tracked pipeline programs.

Pipeline (8)

project

Stereotactic Radiation Therapy

Brain Metastases

Phase 3 · other · active

1 trials project

Temozolomide

Glioblastoma

Phase 3 · small_molecule · active

1 trials project

Cesium-131 brachytherapy

Recurrent Brain Metastases

Phase 2 · other · active

1 trials project

GTB-3550 TriKE® Phase I

High-risk Myelodysplastic Syndromes

Phase 2 · small_molecule · terminated

1 trials project

GTB-5550

Tri-specific Killer Engager

Phase 1 · small_molecule · active

1 trials project

Stereotactic Radiation Therapy

Glioblastoma

Approved · other · terminated

1 trials project

Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)

Glioblastoma

Approved · other · active

1 trials project

Semaglutide

Obesity (Disorder)

Unknown · small_molecule · active

1 trials

Patents (1)

patent

US 10071150

Immunity enhancing therapeutic vaccine for HPV and related diseases

Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)